Cargando…

Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients

Ivermectin has recently shown efficacy against SARS-CoV-2 in-vitro. We retrospectively reviewed severe COVID-19 patients receiving standard doses of ivermectin and we compared clinical and microbiological outcomes with a similar group of patients not receiving ivermectin. No differences were found b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Camprubí, Daniel, Almuedo-Riera, Alex, Martí-Soler, Helena, Soriano, Alex, Hurtado, Juan Carlos, Subirà, Carme, Grau-Pujol, Berta, Krolewiecki, Alejandro, Muñoz, Jose
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657540/ https://www.ncbi.nlm.nih.gov/pubmed/33175880 http://dx.doi.org/10.1371/journal.pone.0242184

Ejemplares similares

Correction: Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients
por: Camprubí, Daniel, et al.
Publicado: (2022)

Pre-exposure prophylaxis with hydroxychloroquine for high-risk healthcare workers during the COVID-19 pandemic: A structured summary of a study protocol for a multicentre, double-blind randomized controlled trial
por: Grau-Pujol, Berta, et al.
Publicado: (2020)

Pharmacokinetic Characterization and Comparative Bioavailability of an Innovative Orodispersible Fixed-Dose Combination of Ivermectin and Albendazole: A Single Dose, Open Label, Sequence Randomized, Crossover Clinical Trial in Healthy Volunteers
por: Algorta, Jaime, et al.
Publicado: (2022)

Safety and pharmacokinetic profile of fixed-dose ivermectin with an innovative 18mg tablet in healthy adult volunteers
por: Muñoz, Jose, et al.
Publicado: (2018)

Standard Dose Ivermectin for COVID-19
por: Buonfrate, Dora, et al.
Publicado: (2021)

Safety and Efficacy of a MEURI Program for the Use of High Dose Ivermectin in COVID-19 Patients
por: Mayer, Marcos Alejandro, et al.
Publicado: (2022)

Lack of detectable short-term effects of a single dose of ivermectin on the human immune system
por: Wilson, Natalie E., et al.
Publicado: (2021)

Malaria prophylaxis approach during COVID-19 pandemic
por: Rodriguez-Valero, Natalia, et al.
Publicado: (2020)

Persistent replication of SARS-CoV-2 in a severely immunocompromised patient treated with several courses of remdesivir
por: Camprubí, Daniel, et al.
Publicado: (2021)

Positive direct antiglobulin test in post-artesunate delayed haemolysis: more than a coincidence?
por: Camprubí, Daniel, et al.
Publicado: (2019)

An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol
por: Krolewiecki, Alejandro, et al.
Publicado: (2022)

Role of DNA-detection–based tools for monitoring the soil-transmitted helminth treatment response in drug-efficacy trials
por: Gandasegui, Javier, et al.
Publicado: (2020)

Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial
por: Krolewiecki, Alejandro, et al.
Publicado: (2021)

Neighbors’ use of water and sanitation facilities can affect children’s health: a cohort study in Mozambique using a spatial approach
por: Grau-Pujol, Berta, et al.
Publicado: (2022)

Performance evaluation of Baermann techniques: The quest for developing a microscopy reference standard for the diagnosis of Strongyloides stercoralis
por: Gelaye, Woyneshet, et al.
Publicado: (2021)

The Strongyloides stercoralis-hookworms association as a path to the estimation of the global burden of strongyloidiasis: A systematic review
por: Fleitas, Pedro E., et al.
Publicado: (2020)

Safety and Pharmacokinetic Assessments of a Novel Ivermectin Nasal Spray Formulation in a Pig Model
por: Errecalde, Jorge, et al.
Publicado: (2021)

Effects of larval exposure to sublethal doses of ivermectin on adult fitness and susceptibility to ivermectin in Anopheles gambiae s.s.
por: Kiuru, Caroline, et al.
Publicado: (2023)

The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID‐19
por: Schmith, Virginia D., et al.
Publicado: (2020)

Macrofilaricidal Efficacy of Repeated Doses of Ivermectin for the Treatment of River Blindness
por: Walker, Martin, et al.
Publicado: (2017)

Cutaneous Larvae Migrans Treated with a Single Dose of Ivermectin
por: Harrison, Iris S., et al.
Publicado: (2022)

Comparison of Repeated Doses of Ivermectin Versus Ivermectin Plus Albendazole for the Treatment of Onchocerciasis: A Randomized, Open-label, Clinical Trial
por: Batsa Debrah, Linda, et al.
Publicado: (2020)

Corrigendum to Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial [EClinicalMedicine 37 (2021) 100,959]”
por: Krolewiecki, Alejandro, et al.
Publicado: (2021)

COVID-19: The Ivermectin African Enigma
por: Guerrero, Rodrigo, et al.
Publicado: (2020)

Effect of Ivermectin and Atorvastatin on Nuclear Localization of Importin Alpha and Drug Target Expression Profiling in Host Cells from Nasopharyngeal Swabs of SARS-CoV-2- Positive Patients
por: Segatori, Valeria Inés, et al.
Publicado: (2021)

Low doses of ivermectin cause sensory and locomotor disorders in dung beetles
por: Verdú, José R., et al.
Publicado: (2015)

Efficacy of High-Dose Albendazole with Ivermectin for Treating Imported Loiasis, Italy
por: Gobbi, Federico, et al.
Publicado: (2019)

Mass ivermectin treatment for Onchocerciasis: Lack of evidence for collateral impact on transmission of Wuchereria bancrofti in areas of co-endemicity
por: Richards, FO, et al.
Publicado: (2005)

Albendazole and ivermectin for the control of soil-transmitted helminths in an area with high prevalence of Strongyloides stercoralis and hookworm in northwestern Argentina: A community-based pragmatic study
por: Echazú, Adriana, et al.
Publicado: (2017)

Cytochrome P450/ABC transporter inhibition simultaneously enhances ivermectin pharmacokinetics in the mammal host and pharmacodynamics in Anopheles gambiae
por: Chaccour, Carlos J., et al.
Publicado: (2017)

Effect of a Single Standard Dose (150–200 μg/kg) of Ivermectin on Loa loa Microfilaremia: Systematic Review and Meta-analysis
por: Pion, Sébastien D, et al.
Publicado: (2019)

Safety of oral administration of high doses of ivermectin by means of biocompatible polyelectrolytes formulation
por: Madrid, Rafael R.M., et al.
Publicado: (2020)

Role of beta-2-microglobulin as a biomarker in very preterm and extremely preterm infants with CNS inflammation
por: Batista Muñoz, Albert, et al.
Publicado: (2019)

Ivermectin and malaria control
por: Ōmura, Satoshi, et al.
Publicado: (2017)

Ivermectin buyers clubs
por: Stokel-Walker, Chris
Publicado: (2021)

Ivermectin-associated SCARs
Publicado: (2022)

Ivermectin and COVID-19
por: Wiwanitkit, Viroj
Publicado: (2021)

Towards soil-transmitted helminths transmission interruption: The impact of diagnostic tools on infection prediction in a low intensity setting in Southern Mozambique
por: Grau-Pujol, Berta, et al.
Publicado: (2021)

Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial
por: Grau-Pujol, Berta, et al.
Publicado: (2021)

Single-Nucleotide Polymorphisms in the Beta-Tubulin Gene and Its Relationship with Treatment Response to Albendazole in Human Soil-Transmitted Helminths in Southern Mozambique
por: Grau-Pujol, Berta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vqb6t1of3n05nj5s4be4c68hqc